David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 63,254 shares at $40.26 ($2.5M) on 2025-12-04, disclosed to the SEC on 2025-12-08.
Scheduled sale ($2.5M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.26 | 31,341 | $1.3M | 49.5% |
| 2 | $40.26 | 31,341 | $1.3M | 49.5% |
| 3 | $40.14 | 572 | $23K | 0.9% |
| Total | $40.26 avg | 63,254 | $2.5M | 100% |
| Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |
| IMCR | SELL | 2025-09-16 | $1.6M | — | Filing → |